Therapeutic Cloning
President Bush probably will not reverse his position on stem cell research, even if it is mostly symbolic (embryos, after all, are destroyed every day in reproductive clinics–perhaps some White House press corps member would ask the president about this someday). The battle over therapeutic cloning, however, goes on in the Senate. And it appears that a ban on such cloning, lacking the support of Senators such as Orrin Hatch and Arlen Specter, probably would not muster a simple majority in the Senate–much less the 60 votes needed to break a filibuster. “The question is whether the Democrats and stem-cell supporters among Republicans can still hang tough,” says one observer, especially when contentious Supreme Court appointments loom in the near future. Some hope that passage of Proposition 71 in California will put pressure on President Bush to change his stem cell policy, a proposition that unfortunately looks unlikely from this president.
Keep Reading
Most Popular
Large language models can do jaw-dropping things. But nobody knows exactly why.
And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.
The problem with plug-in hybrids? Their drivers.
Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.
Google DeepMind’s new generative model makes Super Mario–like games from scratch
Genie learns how to control games by watching hours and hours of video. It could help train next-gen robots too.
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.